Discontinuation report NOVASEN

Last updated on 2018-10-12 History
Report ID 63964
Drug Identification Number 00229296
Brand name NOVASEN
Common or Proper name ACETYLSALICYLIC ACID
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETYLSALICYLIC ACID
Strength(s) 650MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N02BA
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-06-30
Remaining supply date 2018-07-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-10-12 French Compare
v1 2018-10-12 English Compare